Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)


HIZAL M., ŞENDUR M. A. N., YAŞAR H. A., Bir Yucel K., Arslan C., Ucar G., ...More

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol.26, no.7, pp.1583-1589, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 7
  • Publication Date: 2020
  • Doi Number: 10.1177/1078155219900908
  • Journal Name: JOURNAL OF ONCOLOGY PHARMACY PRACTICE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Page Numbers: pp.1583-1589
  • Keywords: Interferon, neutrophil-lymphocyte ratio, prognosis, renal cell cancer, tyrosine kinase inhibitors, PRETREATMENT NEUTROPHIL, INFLAMMATION, CANCER, IMPACT, PROGRESSION, VALIDATION
  • Hacettepe University Affiliated: Yes

Abstract

Background